bibliographic entry 7442064 [be/7442064]
https://w3id.org/oc/corpus/be/7442064

is a
content
  • Zhang, L, Luan, B, Adler, A, Eichten, A, Daly, C, Thurston, G. Abstract 2723: Sarilumab (REGN88), a fully-human anti-IL6R antibody, inhibits tumor growth in preclinical models, as a single agent and in combination with the VEGF blocker aflibercept, Cancer Res, 2012, 72, 2723, 2723
references